Matches in Wikidata for { <http://www.wikidata.org/entity/Q59254034> ?p ?o ?g. }
Showing items 1 to 53 of
53
with 100 items per page.
- Q59254034 description "im Jahr 2010 veröffentlichter wissenschaftlicher Artikel" @default.
- Q59254034 description "wetenschappelijk artikel" @default.
- Q59254034 description "наукова стаття, опублікована у 2010" @default.
- Q59254034 name "Lopinavir/r + Efavirenz combination as a potent NRTI sparing antiretroviral therapy" @default.
- Q59254034 name "Lopinavir/r + Efavirenz combination as a potent NRTI sparing antiretroviral therapy" @default.
- Q59254034 type Item @default.
- Q59254034 label "Lopinavir/r + Efavirenz combination as a potent NRTI sparing antiretroviral therapy" @default.
- Q59254034 label "Lopinavir/r + Efavirenz combination as a potent NRTI sparing antiretroviral therapy" @default.
- Q59254034 prefLabel "Lopinavir/r + Efavirenz combination as a potent NRTI sparing antiretroviral therapy" @default.
- Q59254034 prefLabel "Lopinavir/r + Efavirenz combination as a potent NRTI sparing antiretroviral therapy" @default.
- Q59254034 P1433 Q59254034-5B906C79-266D-422F-90EC-9A57D89D331B @default.
- Q59254034 P1476 Q59254034-74B9C2CF-3600-4410-9BF5-51F2975B0DFE @default.
- Q59254034 P2093 Q59254034-71EB95E6-EBFA-4E57-B8F9-46A69900ABA9 @default.
- Q59254034 P2093 Q59254034-7233C0A8-FA27-432C-88A2-EDBE826EFE02 @default.
- Q59254034 P2093 Q59254034-E17B4971-A3FA-48DB-AA42-03536E180AE3 @default.
- Q59254034 P2093 Q59254034-F7A5303F-01B9-44A5-829A-1B0BBFC47772 @default.
- Q59254034 P275 Q59254034-54817cbe-15ae-48a5-a5f9-837121d44085 @default.
- Q59254034 P2888 Q59254034-06CDCE1C-B732-4478-8620-8BE8DBD34934 @default.
- Q59254034 P304 Q59254034-A4EEE9D7-65A2-436D-AACA-3BC4C9F70EDE @default.
- Q59254034 P31 Q59254034-F8931D65-09B5-46FA-8602-C35273B513E2 @default.
- Q59254034 P356 Q59254034-4AEF137E-3569-45CA-987B-6401CC9780F0 @default.
- Q59254034 P433 Q59254034-9D48406B-7200-49B4-880B-2274EA4FB403 @default.
- Q59254034 P478 Q59254034-36D3B475-513F-4A87-BA58-21D90B66ABC4 @default.
- Q59254034 P50 Q59254034-9A51177E-A07F-49B7-8300-5C103F0CD10A @default.
- Q59254034 P50 Q59254034-E9F26CD9-5B19-4455-AF9B-C95469A31895 @default.
- Q59254034 P577 Q59254034-7B1A22AC-4128-489A-9BA9-7210CABB8769 @default.
- Q59254034 P6179 Q59254034-A731FC0A-3105-4BD9-811E-D3E298711959 @default.
- Q59254034 P6216 Q59254034-a522b1d9-f68a-4db1-baec-092c0b8095e8 @default.
- Q59254034 P921 Q59254034-8EEEDCA5-2F4F-4D28-B72F-3448A99ADFA2 @default.
- Q59254034 P921 Q59254034-B4E6DEE3-AE1C-44AE-850F-9202BBFAB363 @default.
- Q59254034 P932 Q59254034-DB6AF4BE-B94A-4B31-A1E0-F7491DB191EC @default.
- Q59254034 P356 1742-4690-7-S1-P55 @default.
- Q59254034 P1433 Q15793508 @default.
- Q59254034 P1476 "Lopinavir/r + Efavirenz combination as a potent NRTI sparing antiretroviral therapy" @default.
- Q59254034 P2093 "Benoît Kabamba" @default.
- Q59254034 P2093 "Patrick Goubau" @default.
- Q59254034 P2093 "Philippe Henrivaux" @default.
- Q59254034 P2093 "Yvette Fairon" @default.
- Q59254034 P275 Q19125117 @default.
- Q59254034 P2888 1742-4690-7-s1-p55 @default.
- Q59254034 P304 "P55" @default.
- Q59254034 P31 Q13442814 @default.
- Q59254034 P356 "10.1186/1742-4690-7-S1-P55" @default.
- Q59254034 P433 "Suppl 1" @default.
- Q59254034 P478 "7" @default.
- Q59254034 P50 Q114886077 @default.
- Q59254034 P50 Q98900834 @default.
- Q59254034 P577 "2010-01-01T00:00:00Z" @default.
- Q59254034 P6179 "1008473236" @default.
- Q59254034 P6216 Q50423863 @default.
- Q59254034 P921 Q422585 @default.
- Q59254034 P921 Q422645 @default.
- Q59254034 P932 "3316105" @default.